High concordance between polymerase chain reaction and antibody testing ofspecimens from individuals dually infected with HIV types 1 and 2 in Guinea-Bissau, West Africa
L. Walther-jallow et al., High concordance between polymerase chain reaction and antibody testing ofspecimens from individuals dually infected with HIV types 1 and 2 in Guinea-Bissau, West Africa, AIDS RES H, 15(11), 1999, pp. 957-962
In this study we have evaluated the concordance between serology, using fiv
e commercially available antibody assays designed to discriminate between H
IV-1 and HIV-2, and the polymerase chain reaction (PCR) for the detection o
f HIV-1 and HIV-2 dual infection, Thirty-seven HIV-1 and HIV-2 dually react
ive serum samples from individuals in Guinea-Bissau with total CD4(+) rr ly
mphocyte counts ranging from 9 to 948 x 10(6)/liter were included in the st
udy. All samples were tested by Multispot, Pepti-LAV, and Immunocomb HIV-1
and HIV-2 discriminatory antibody assays. Thirty-two of the 37 samples were
also tested by a combination of two HIV type-specific antibody enzyme-link
ed immunosorbent assays (ELISA; Wellcozyme HIV-1 and Murex HIV-2). Each sam
ple showed dual reactivity in all or any of these assays. A nested PCR base
d on primer systems in the vif and pol regions of HIV-1 and in the gag and
LTR regions of HIV-2 was used to evaluate the serological results, Thirty s
amples from HIV-1 antibody-positive individuals and 30 samples from HIV-2 a
ntibody-positive individuals were all PCR positive with their corresponding
primer systems, The type specificity was 100% for all of the primer system
s, The concordance between dual HIV-1 and HIV-2 reactivity on the serologic
al assays and PCR was 77.7% for Multispot, 80% for Pepti-LAV, 81.8% for Imm
unocomb, and 85.7% for the two ELISAs used in combination. Thus the majorit
y of individuals included in this study appeared to be truly dually infecte
d, The study shows that it is possible, through a careful selection of assa
ys, to reach a high concordance between serological assays and PCR in study
ing HIV-1 and HIV-2 dual infections.